Journal of Immunology Research / 2024 / Article / Tab 3 / Review Article
Challenges in Emerging Vaccines and Future Promising Candidates against SARS-CoV-2 Variants Table 3 Schedule for different COVID-19 vaccines.
Vaccine Dose Interval (days) Booster requirement ChAdOx1 nCoV-19 [76 –81 ] 2 56–84 A first booster after 4–6 months of primary series. Vaccine efficacy against asymptomatic and moderate SARS-CoV-2 infection gradually gets weak over time Ad26.CoV2.S [81 ] 1 — — BBIBP-CorV [6 ] [82 , 83 ] 2 21 A first booster after 4–5 months of primary series BBV152-Covaxin [4 ] [84 , 85 ] 2 28 A first booster after 4–6 months of primary series. Vaccine efficacy against asymptomatic and moderate SARS-CoV-2 infection gradually gets weak over time CoronaVac [86 ] 2 14 A first booster after 4–6 months of primary series. mRNA-1,273 [7 ] 2 28 A first booster for the highest priority use group (after 4–6 months of primary series). A second booster after 4–6 months of the first booster dose BNT162b2 [87 ] 2 21 First booster for highest priority group (after 4–6 months of primary series). A second booster after 4–6 months of the first booster dose Gam-COVID-Vac [88 ] 1 — A first booster after 21 days of the primary dose NVX-CoV2373 [89 ] 2 56 days A first booster dose after 4–6 months of the initial series. A second booster dose is 4–6 months after the first booster dose